Explore the vast range of titles available.

IntroductionSchizophrenia is a chronic psychiatric disorder with disorganization progressive and important affecting several spheres: thought, affectivity, cognition and social life of the subject. It is a serious mental disorder with a prevalence of nearly 1%.Men would present more premorbid difficulties, but the overall prevalence of symptoms of schizophrenia is similar in both sexes.When it comes to comorbidity, men and women are vulnerable to somewhat different health issues.Anxiety symptoms are one of the main symptoms in patients with schizophrenia, but the effect of anxiety symptoms on patients is easily overlooked.About 40% have persistent anxiety symptoms in patients with schizophrenia, and whether they are accompanied depressive symptoms, the symptoms may have a greater impact on the patients. We need to help patients avoid suicide when the symptoms depression appear.Hallucinations auditory, anxiety symptoms and depressive symptoms may exist simultaneously in patients with schizophrenia.Most studies focus on studying the relationship between auditory hallucinatory symptoms and depressive symptoms in patients with schizophrenia, the relationship between auditory hallucinatory symptoms and anxiety symptoms, or the relationship between anxiety symptoms and symptoms depressiveObjectivesThe objective of this study is to resolve important questions concerning the interaction of anxiety and schizophrenia in patients followed in psychiatry at Arrazi Hospital .MethodsDescriptive and analytical cross-sectional study, conducted over a period from May 2022 to October 2022 in patients consulted in Arrazi de Salé, using a questionnaire grouping together the sociodemographic characteristics, the risks and the advantages of antipsychotics, medical comorbidities and the mobilization of psychosocial support, and thus the BPRS Anxiety Rating Scale.ResultsOf the 42 patients who completed the study, 18 were female and 24 were male 60% were single. The average age was 36.63 years, 60% have secondary education, 25% primary, and 15% university level, 30% have a family history of schizophrenia.32 were taking an atypical antipsychotic, 10 were taking classic neuroleptics.Most schizophrenics encountered in psychiatry are stabilized on antipsychotic treatment, and those who have an anxious comorbidity are still too often underestimated , put on the account of the positive symptoms and the negative symptoms of schizophrenia, it is insufficiently diagnosed and treated.The effect of anxiety symptoms on patients is easily overlooked.It should be kept in mind that anxiety in schizophrenia requires special attention when discussing and prescribing antipsychotic medications.ConclusionsOptimal interventions for patients with comorbid schizophrenia and anxiety differ by quality of life.At all consultations, preventive strategies should consider mindful interviews and the risks and benefits of treatment for schizophrenia and comorbidities.Disclosure of InterestNone Declared

IntroductionDepression in psychosis has been more or less neglected as a field of study, due to its vague nosographic framework. Some studies have nevertheless focused on certain features of depression in psychosis, such as post-psychotic depression. This is a frequent phenomenon with a nosographic and etiopathogenic complexity that can lead to confusion.ObjectivesTo study the characteristics of post-psychotic depression and compare results with those in the literature.MethodsIt is a prospective, descriptive, case series study conducted at the Ar-Razi psychiatric hospital in Salé. Inclusion criteria were patients diagnosed with a brief psychotic disorder, schizophreniform disorder or schizophrenia, in remission, who met the criteria for a DSM 5 characterized depressive episode. Data are collected during the psychiatric interview with the patient, using a questionnaire.ResultsOngoingConclusionsOngoingDisclosure of InterestNone Declared

IntroductionThe quantification of suicidal risk in specific populations is important for the adoption of prevention and risk reduction measures. This risk remains very high in patients with eating disorders compared to the general population.ObjectivesThe present study evaluates the prevalence of suicide among patients with eating disorders all seeking different suicidal risk factors in these patients.MethodsA retrospective study of medical records of all patients with eating disorders, diagnosed according to DSM 5 criteria, at Arrazi hospital of Salé for the past 14 years, by assessing the prevalence of suicide attempts and care.ResultsIn our work, all patients are female, 17 years old on average, 18 patients out of 20 have anorexia nervosa, 4 of them have had bouts of bulimia, and only one patient was admitted for management of bulimia nervosa alone. The mean age of onset was 15 years with addictive comorbidity in 5 patients.Thirteen patients had comorbid depressive disorder, one patient was schizophrenic and six patients had borderline personality disorder.12 patients have made suicide attempts, planned especially in a depressive environment.ConclusionsPreventive management of suicidal risk must be taken in order to improve the prognosis in this category of patients.DisclosureNo significant relationships.

IntroductionHospitalization in psychiatry is marked by the use of care without consent.We therefore proposed to study from this perspective the feelings and opinions of patients on such an experience.ObjectivesThe objective of this work is to explore the experiences of patients and their perception of the effects of this hospitalization, through 3 fundamental ethical principles: Autonomy, beneficence and non-maleficence.MethodsThis study will be conducted at Arrazi Psychitaric Hospital, in patients at the end of their stay, via a questionnaire.ResultsA total of 122 patients attended the study. A very large proportion of patients were satisfied with the premises, space planning, and had knowledge of a structured planning of the organization of care. A senior doctor was identified by 95% of them. Eighty five per cent were free to move around in the hospital.The information on the care offered was perceived by 83.7%. The rates are lower with respect to clear explanations received on the disease, the effects of drugs and the type of hospitalization.Regarding the feelings experienced during the stay, 83% of people who spoke mentioned a painful experience. The feelings that prevailed were a feeling of helplessness, fear, worthlessness. On the other hand, a majority of patients expressed that the hospitalization had protective effects towards themselves and towards others, but that it wasn’t justified.ConclusionsThese results suggest that autonomy and beneficence are respected. Therefore, an attention should be paid to various information given during the stay.DisclosureNo significant relationships.

IntroductionFor many years, the question of the announcement of the diagnosis in psychiatry has been controversial. It is the starting point of a management allowing access to psychoeducation and to the patient’s recovery. In the case of schizophrenia, the cognitive impairment and the stigmatizing nature of the pathology jeopardize the announcement of the diagnosis. However, recommendations and legislation emphasize the need to inform the patient about his or her pathology. In Morocco, the law n° 131-13 of February 19, 2015 relating to the practice of medicine has made information about the diagnosis to patients an obligation for doctors and a right for patientsObjectivesThe interest of our work is to try to evaluate the current state of this practice, its ethics and its representations among psychiatrists.MethodsThis is a descriptive study on the announcement of the diagnosis of schizophrenia in a population of psychiatrists. The data collection was carried out by a questionnaire including: Socio-demographic and professional data, opinion on practice and training concerning diagnostic announcement in psychiatry, physicians’ representations concerning announcement: frequency, opinion on the importance of this practice.Results31 participants responded to our questionnaire. More than 9 out of 10 participants would not benefit from training on diagnostic announcement. Only 22.6% of physicians reported being very or somewhat familiar with medical information laws and their content regarding the regulation of diagnostic announcement. All participants considered schizophrenia to be the most difficult pathology to announce, followed by personality disorders and bipolar disorder. 74.2 of the participants considered it “rather” or “completely” essential to inform the patient of his or her psychiatric diagnosis. 77.4% of the participants considered it necessary to announce the diagnosis of schizophrenia and 80.7 often or systematically announce this diagnosis. Three situations considered appropriate to announce a diagnosis of schizophrenia: 74.2% announce it in general when the patient or the family asks for information about the diagnosis, 42% advise the patient when he/she mentions schizophrenia on his/her own. The patient’s functional inability to understand the diagnosis (77.4%) and the fear of negative clinical and therapeutic repercussions (41.9 and 38.7 respectively) were reported to deter physicians from making the announcement. More than half of the participants (64.5%) thought that the announcement of the diagnosis improved therapeutic compliance. Conversely, 35.5% considered that the announcement had no impact on therapeutic compliance.ConclusionsThe announcement of the diagnosis of schizophrenia remains today a complex and evolving subject. Even if great progress has been made to inform patients as well as possible, practices remain disparate from one doctor to another and this information is not well traced.Disclosure of InterestNone Declared

IntroductionSchizophrenia is a severe mental disorder marked by abnormal interpretations of reality, often resulting in hallucinations, delusions, and disordered thinking that significantly impairs daily functioning and can be disabling. Lifelong treatment is necessary, and early intervention can help manage symptoms and improve long-term outcomes.Polycythemia Vera (PV) is a chronic myeloproliferative neoplasm causing an excess of red blood cells in the peripheral blood (polyglobulia). While the disease typically presents with symptoms, it can also be asymptomatic and discovered incidentally during routine laboratory tests, leading to a diagnosis of polycythemia when no secondary cause is apparent.While early 20th-century literature linked PV to intense neurological and psychiatric symptoms, contemporary studies rarely make such references.ObjectivesThe aim of this study is to explore, through a clinical case of a patient undergoing treatment for treatment-resistant schizophrenia with clozapine, and concurrently diagnosed with Polycythemia Vera, the potential causes of this condition. We seek to discern whether it represents mere comorbidities or if Polycythemia Vera is an adverse effect of antipsychotic treatment, particularly with clozapine.MethodsA 41-year-old patient, with a history of cranial trauma at the age of 5 and 19 years of treatment for schizophrenia, also has a tobacco use disorder. While hospitalized for the management of symptomatic reactivation of schizophrenia, despite being on clozapine, the patient underwent various therapeutic combinations with no observed clinical improvement. A few months later, follow-up blood tests indicated an elevation in all blood cell lines.An internal medicine consultation was sought, resulting in the diagnosis of Polycythemia Vera.ResultsThe evaluations conducted led us to the conclusion that there are two distinct nosological entities, with the treatment of the psychiatric condition revealing true polycythemia. Even after reducing the doses of clozapine and changing the atypical antipsychotic, all subsequent evaluations showed no effectiveness in managing the psychiatric disorder or improvement in the hematological condition.ConclusionsIn summary, schizophrenia is a severe and lifelong mental disorder requiring early intervention for symptom management. Polycythemia Vera (PV), a myeloproliferative disorder, typically presents with symptoms but can also be asymptomatic.While early literature linked PV to intense neurological and psychiatric symptoms, contemporary studies seldom reference such associations. The coexistence of schizophrenia and PV in a patient underscores the need for comprehensive and interdisciplinary care to address the complex interplay between mental and physical health. Further research is needed to deepen our understanding of concurrent psychiatric and hematological conditions.Disclosure of InterestNone Declared

IntroductionBipolar disorder is a severe and chronic mental pathology, with an estimated prevalence of 1% in the general population. It is a complex pathology, encompassing a wide variety of severe and contradictory symptoms, with harmful repercussions on the patient’s personal, emotional, social, professional and conjugal life, precipitating relapse. By improving our knowledge of bipolar disorder, we can support and accompany patients, helping them to understand their illness, to be able to manage it, to resolve the problems that may arise from it, and to prevent relapses and the occurrence of further episodes.ObjectivesThe aim of our work is to explore maladaptive early patterns in people with bipolar disorder in the intercritical period in relation to their symptomatology and functional disability, given that consideration of maladaptive early patterns (IAPs) could lead to better identification, understanding and management of bipolar disorder.MethodsWe conducted a cross-sectional, descriptive and analytical study. The sample in our study consisted of 40 bipolar adults and 40 control adults, recruited from the various inpatient and outpatient departments of our hospital. They were all university graduates, aged between 20 and 60, followed for at least 06 months and stabilized on treatment. After collecting the various socio-demographic and clinical data, we used the Young schema questionnaire-short form (YSQ-S1).ResultsOur study sample seemed to be characterized by certain specificities: high “self-sacrifice”, “high demands” and “exaggerated personal rights”. Feelings of dependence and incompetence were also high among our patients, especially those with type I bipolar disorder, leading to a marked decline in self-esteem and autonomy.ConclusionsThe data we have retained from this work show us the importance of drug, psychotherapeutic and family management in achieving thymic stability and psychological and relational well-being.Disclosure of InterestNone Declared

IntroductionCannabis is an illicit substance whose use is very common among the patients we see daily in hospitals. Its use is not simply a “recreational” desire, but above all an attempt at self-medication in order to manage emotions that have become too painful. However, even if cannabis reduces the symptomatology in the moment, it worsens most psychiatric pathologies.ObjectivesThe purpose of this study is to assess the experiences of cannabis users’ families.MethodsThe survey was carried out among the families of patients hospitalized at the Arrazi Hospital in Salé and those followed in consultation and who use cannabis. The collection of information is done with the help of an exploitation form.Results34.6% of the participating families put bad company as the cause of consumption, followed by family problems, psychiatric problems come in 3rd position with a percentage of 19.2%. Cannabis use is considered as a disease in 52.8% of the families participating in the study. 58.5% of the families distinguish between good and bad cannabis use and define bad use by the use of large quantities of cannabis in 34.2% of the cases. The majority of the participating families (86.8%) saw cannabis as aggravating their loved one’s mental illness.ConclusionsThe understanding of the perceptions of the families towards the use of cannabis by their close relatives as well as the correction of the false perceptions will help to establish better prevention programs and better patient care especially with the family therapy which showed its utility in the management of the patients having disorders related to the use of cannabis.Disclosure of InterestNone Declared

IntroductionChildbirth can be a very painful experience, especially vaginally. It can have many complications. The obstetrical complications of caesarean section are well studied but its psychological complications are little mentioned. Most women recover quickly after giving birth, but others seem to have more difficulty. Researchers have attempted to identify perinatal risk factors for the development of post-traumatic stress disorder in parturients and caesarean section seems to be one of the predictors.ObjectivesThe objective of our study is to detect post traumatic stress disorder in women after vaginal delivery.MethodsThis is a cross-sectional descriptive study conducted among women from the general population who have given birth vaginally. The information was collected using a questionnaire distributed on social networks. Symptom severity was quantified using the PTSD checklist for DSM-V (PCL-5).PCL-5 is a 20-item self-assessment that measures the 20 DSM-5 symptoms of PTSD. She rates each symptom from 0 (not at all) to 4 (extremely). The score varies from 0 to 80. A threshold of 33 allows screening for post-traumatic stress disorder.Results61 women took part in this study, 81.5% of whom gave birth vaginally between the ages of 20 and 30.70.3% of the participants gave birth vaginally once, 44.4% twice and 7.3% of the women in our sample had a caesarean three times.Regarding the indication of the high way in our sample: the narrowing of the pelvis and fetal distress were in 22.2%. Exceeding term was in 18.5% of cases.In our sample, 59.3% of the women had planned their vaginal delivery and 40.7% had given birth urgently.Regarding the results of the PCL-5 scale (PTSD checklist for DSM-V), the score varies between 0 and 48 with a median score equal to 12. 3.7% of the participants had a score greater than 33.ConclusionsPost-traumatic stress disorder can accompany childbirth, especially when it is high and in an emergency. Postpartum post traumatic stress disorder affects the mother-child relationship and can be complicated by depressive disorder. Medical monitoring of pregnancy, good medical and family support for the parturient and preparation for childbirth are necessary to better start the maternity experience.Disclosure of InterestNone Declared

IntroductionIn terms of care, family has a major role to play in the evolution of psychiatric illness.Our aim in this work is to determine the family experience during the hospitalization of their sibling in the emergency room of the psychiatric university hospital Ar-Razi in Salé.ObjectivesOur aim in this work is to determine the family experience during the hospitalization of their sibling in the emergency room of the psychiatric university hospital Ar-Razi in Salé.MethodsOur work was carried out with families of patients admitted to the emergency department of the psychiatric university hospital Ar-Razi in Salé.The data collection was carried out with the help of a questionnaire including several items.ResultsSixty-five family members were included in this study. Their relatives hospitalized in the psychiatric emergency department were male in 70% of cases with an average age of 32.4 years.- In 76% of the cases, the family member interviewed was the one who requested hospitalization;- 55% of those interviewed were parents.The analysis of relatives’ feelings during the hospitalization showed:- Feelings of guilt were related to feelings of fear of exclusion and worries.- Feelings of fear and exclusion were mostly expressed by mothers of patients hospitalized for the first timeAt the end of the hospitalisation, 90% expressed relief, and 85% of family members were satisfied with their relative’s stay in the psychiatric emergency department.ConclusionsRecognizing families as units of care and understanding their situation and experiences facilitates the post-hospitalization care process. A well-informed family about mental illness and the types of therapeutic treatments available helps optimize the treatment.Disclosure of InterestNone Declared